“ Arnaud Pradel, Product Development Director and Co-Segment Leader of HORIBA Medical reveals how HORIBA has over 30 years of experience when it comes to launching products… ”
In Conversation
“ CFCII's Director provides us with an overview of the services offered to French and Italian companies by the Chamber, as well as her perceptions about investments… ”
“ The president of the family-run Laboratoires Panpharma, a specialist in injectable drugs for the hospital sector, reveals how they have affiliates in both France and Germany, are… ”
“ Bart van de Kerkhof highlights how Covidien’s acquisition will drive Medtronic to new heights thanks to a broader product portfolio. Medtronic is already piloting projects and cooperating… ”
“ Anita Atema, General Manager of Celgene, reveals Celgene’s inspiring and concrete initiatives that illustrate how a true willingness to cooperate with healthcare stakeholders and a remarkable effort… ”
“ Anna Van Poucke, Partner and Chairman at KPMG Healthcare in the Netherlands, explains how KPMG can helps its partners and clients move forward towards a better… ”
“ Alberto Gugliemo, President of the Carlo Besta Institute in Milan, shares the changing perception of neurological diseases and neurological science in Italy, the nature of the… ”
“ Francesco Carugi, Managing Director at Grifols Italy, discusses the company's presence in the plasma, plasma products and plasma diagnostics segments, the impact of the liberalization of the… ”
“ As the founder of Egypt’s leading commercial agent for advanced medical technologies, Mahmoud Bagneid has a simple goal for Egyptian healthcare; for all Egyptian’s to be… ”
“ Daniel de Labauve d’Arifat discusses how to accomplish the new Mauritian government's Vision 2030 strategy, his company’s successful track record as the main wholesaler and distributor of… ”
“ Egypt is at the ‘golden stage’ for investment, claims Boehringer Ingelheim country head Mohamed El-Sahhar, who explains how the company is expanding their organization in Egypt… ”
“ Amgen Netherlands is preparing to launch five new products next year, including their leading cardiovascular biotech product Repatha and recently announced the acquisition of the Dutch… ”
